Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: S D Med. 2021 Feb;74(2):70–74.

Table 3.

Results of data analysis.

Variable CDT n=283 Systemic heparin n=58 p-value

Length of stay (days) 3.44 6.47 <0.001
Pulmonary hypertension by 12 months 14 (6.3) 7(15.9) 0.030
Right heart strain 164 (58.0) 13 (22.4) <0.001
Hypotension 36 (12.7) 6 (103) 0.616
Thirty-day mortality 11 (3.9) 4(6.9) 0.309
Thirty-day readmission 18 (6.4) 9 (155) 0.019
Return to phot living conditions 262 (89.0) 46(79.3) 0.042
Bleeding complications 12(4.2) 8 (13.8) 0.005

Values listed are n-values with percent of occurrence listed in parentheses